U.S. Urology Devices Market, By Product Type (Dialysis Equipment, Urinary Stone Treatment Devices, Endoscopy Devices, Benign Prostatic Hyperplasia Treatment Devices, Urinary Incontinence & Pelvic Organ Prolapsed and Other Products), Type (Instruments and Consumables & Accessories), Indication (Kidney Diseases, Overactive Bladder, Hematuria, Urinary Tract Infection, Kidney Stones, Premature Ejaculation, Benign Prostatic Hyperplasia, Urological Cancer, Pelvic Organ Prolapse, Urethrotomies, Urethral Stricture and Other Disease), Technology (Minimally Invasive Surgery, Robotic Surgery and Others), End User (Hospitals & Clinics, Dialysis Centers, Clinical Research Laboratories, Academic Institutes and Others), Distribution Channel (Direct Tenders, Third Party Distribution and Others), Country (U.S.) Industry Trends & Forecast to 2029.
Market Analysis and Insights: U.S. Urology Devices Market
The U.S. urology devices market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.3% in the forecast period of 2022 to 2029 and is expected to reach USD 16,249.70 million by 2029. Rising healthcare expenditure and increased interest towards minimally invasive surgery act as driver for the urology devices market growth.
Urology devices and supplies are products that are designed for people who have urologic diseases, urinary retention and need help removing urine from the body. Urologic diseases or conditions include urinary tract infections, kidney stones, bladder control problems and prostate problems and more. Urology devices includes wide range of products such as urology operating tables, urological examination tables, chairs, urology ultrasound imaging systems, bladder scanners, urodynamic systems, urinary flow meters, intra corporeal lithotripters, extra corporeal lithotripters, urological lasers, urology forceps, prostate biopsy needles, meshes, stents, catheters, drainage sets and bags, stimulators, probes, cancer test kits and implants. These devices are used for both diagnosis and urology treatment procedures. Common urology procedures that are done includes vasectomy, vasectomy reversal, cystoscopy, prostate procedure, lithotripsy and among more. Some urologic conditions last only short time while others are long lasting. Common symptoms in urology problems are difficulty urinating, pain or burning while urinating, blood or other discharge in urine, fever, chills, lower back pain and pain in genitals.
The U.S. urology devices market is growing in the forecast year due to the rise in market players and the availability of advanced products owing to the increasing incidence of urology conditions. Along with this, manufacturers are engaged in R&D activity for launching novel products in the market with successful product approvals. However, the high cost of urology devices and lack of awareness about urological treatment and devices with product recalls may hamper the growth of the U.S. urology devices market in the forecast period.
The rising healthcare expenditure and increased interest towards minimally invasive surgery are opportunities for the market growth. The strategic initiatives by market players are giving further opportunity to the market to enhance the treatment. However, the lack of skilled professionals and stringent regulatory framework are challenging the market growth.
The urology devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the urology devices market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Urology Devices Market Scope and Market Size
The U.S. urology devices market is segmented on basis of product type, type, indication, technology, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the U.S. urology devices market is segmented into dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, urinary incontinence & pelvic organ prolapsed and other products. In 2022, dialysis equipment segment is expected to dominate the market due to increasing prevalence of kidney failure cases among geriatric population.
- On the basis of type, the U.S. urology devices market is segmented into instruments and consumables and accessories. In 2022, instruments segment is expected to dominate the market due to increasing research activities and market players in the country.
- On the basis of indication, the U.S. urology devices market is segmented into kidney diseases, overactive bladder, hematuria, urinary tract infection, kidney stones, premature ejaculation, benign prostatic hyperplasia, urological cancer, pelvic organ prolapse, urethrotomies, urethral stricture and other disease. In 2022, kidney diseases segment is expected to dominate the market due to rising geriatric population and high diabetes cases in the country.
- On the basis of technology, the U.S. urology devices market is segmented into minimally invasive surgery, robotic surgery and others. In 2022, minimally invasive surgery segment is expected to dominate the market as they are more advanced and highly preferred.
- On the basis of end user, the U.S. urology devices market is segmented into hospitals & clinics, dialysis centers, clinical research laboratories, academic institutes and others. In 2022, hospitals & clinics segment is expected to dominate the market as the number of hospitals with advanced urological procedures are high in the country.
- On the basis of distribution channel, the U.S. urology devices market is segmented into direct tenders, third party distribution and others. In 2022, direct tenders segment is expected to dominate the market as the channel provides best products directly from the manufacturing unit.
Urology devices Market Country Level Analysis
The urology devices market is analyzed and market size information is provided by the country, product type, type, indication, technology, end user and distribution channel as referenced above.
The countries covered in the urology devices market report are the U.S.
U.S is expected to grow with the highest growth rate in the forecast period of 2022 to 2029 because of increasing prevalence of urologic conditions.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of U.S. brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Urology Devices Treatment, is Boosting the Market Growth of Urology Devices Market.
The urology devices market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2011 to 2020.
Competitive Landscape and Urology Devices Market Share Analysis
Urology devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to urology devices market.
The major companies which are dealing in the urology devices are Medtronic, Siemens, CooperSurgical, Inc., General Electric, BD, Stryker, Boston Scientific Corporation, Cardinal Health., Intuitive Surgical., Cook, Olympus Corporation, Med pro Medical B.V., Fresenius Medical Care AG & Co. KGaA, Baxter., Richard Wolf GmbH., Dornier MedTech., KARL STORZ SE & Co. Kg, Dale Medical Products, Inc., Healthtronics, Inc., Medi Tech Devices Pvt. Ltd., Coloplast Corp., Remington MEDICAL, Medi-Globe GmbH, Nikkiso Co., Ltd., B. Braun Melsungen AG, Lumenis Be Ltd., Teleflex Incorporated, Urocare Products, Inc., Dynarex Corporation and among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the urology devices market.
For instance,
- In January, 2022, Stryker (U.S.) acquired Vocera Communications (U.S) which is a leader in the digital care coordination and communication category. This acquisition helped company in expanding the innovative portfolio of Stryker’s Medical division propelling the market growth.
- In October, 2021, Medtronic announced that the company received CE mark for their urologic product “Hugo robotic-assisted surgery (RAS) system” which is authorized for sale in Europe. The CE mark approval increased the products quality in urologic and gynecologic procedures which make up about half of all robotic procedures performed today. This improved company’s position over market
- In November, 2020, Coloplast Corp. announced that the company acquired Nine Continents Medical, Inc. which is an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. This acquisition helped company in improving opportunities over interventional urology business to bring innovative solutions to the market.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the veterinary infusion pumps market which also provides the benefit for organization’s profit growth.
SKU-